Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

673.00INR
5:29am EST
Change (% chg)

Rs-2.70 (-0.40%)
Prev Close
Rs675.70
Open
Rs678.00
Day's High
Rs682.80
Day's Low
Rs671.25
Volume
3,298,719
Avg. Vol
3,595,853
52-wk High
Rs898.45
52-wk Low
Rs571.90

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries exec says pricing pressure in the U.S. will continue
Thursday, 10 Nov 2016 08:36am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries exec says awaiting US FDA reinspection of Halol plant . Sun Pharmaceutical Industries exec says pricing pressure in US will continue . Sun Pharmaceutical Industries exec says "there are technical challenges in our ability to launch Glumetza" generic ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Sun Pharmaceutical Industries approves amalgamation of 4 units into co
Thursday, 10 Nov 2016 05:42am EST 

Sun Pharmaceutical Industries Ltd :Says approves scheme of amalgamation of Sun Pharma Medisales, Ranbaxy Drugs Ltd, Gufic Pharma, Vidyut Investments into co.  Full Article

Sun Pharmaceutical Industries on track to achieve benefits from Ranbaxy acquisition
Thursday, 10 Nov 2016 05:39am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries Ltd says synergies from the Ranbaxy acquisition are gaining momentum and co on track to achieve the targeted benefits .Sun Pharmaceutical Industries Ltd says sales in the US were US$ 555 million for the quarter, a growth of 9% over same period last year.  Full Article

Auven Therapeutics announces sale of Ocular Technologies to Sun Pharma
Wednesday, 26 Oct 2016 11:43am EDT 

Auven Therapeutics : Auven Therapeutics announces sale of Ocular Technologies to Sun Pharma . Auven Therapeutics-sale of 100 percent of Ocular Technologies Sarl to a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd .Auven Therapeutics- co will receive an upfront payment of $40 million plus substantial contingent development and sales milestones.  Full Article

Beijing Science Sun Pharmaceutical unit to pay penalty of 0.3 mln yuan
Friday, 19 Aug 2016 04:05am EDT 

Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>: Says its unit received report of administrative punishment from environmental protection department .Says the unit was ordered to pay penalty of about 0.3 million yuan regarding its wastewater discharge.  Full Article

Sun Pharmaceutical Industries June-qtr consol profit rises almost fourfold
Friday, 12 Aug 2016 04:46am EDT 

Sun Pharmaceutical Industries Ltd : June-quarter consol net profit 20.34 billion rupees . June-quarter consol total income from operations 82.43 billion rupees . June-quarter net profit consensus forecast was 19.04 billion rupees . Consol net profit in June-quarter last year was 5.56 billion rupees as per Ind-AS; consol net sales was 67.61 billion rupees .  Full Article

Sun Pharmaceutical extends Imatinib Mesylate Savings Card program benefits for patients in USA
Monday, 8 Aug 2016 08:32am EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma extends Imatinib Mesylate Savings Card program benefits for patients in USA . Co will continue to offer up to US$ 700 reduction on each eligible patient's initial out-of-pocket cost from their commercial insurer . Benefit will cover a patient's monthly fills for a 30-day supply of Sun pharma's imatinib mesylate prescribed for ph+cml, . Will also continue hub service wherein patients can call and speak with a trained healthcare professional .  Full Article

India's Sun Pharma gets FDA nod for generic Glumetza
Monday, 1 Aug 2016 11:44pm EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma announces U.S. FDA approval for generic Glumetza . The commercial launch of the tablets in the U.S. is expected over the next few weeks .  Full Article

Sun Pharma and Almirall signs license deal for Psoriasis treatment
Wednesday, 27 Jul 2016 10:32pm EDT 

Sun Pharmaceutical Industries Ltd : Almirall and Sun Pharma enter into a license agreement for Tildrakizumab in Europe for Psoriasis . To receive development & regulatory milestone payments, royalties, the terms of which are confidential .  Full Article

Almirall signs license deal with Sun Pharma for psoriasis treatment
Wednesday, 27 Jul 2016 11:57am EDT 

Almirall SA : Says enters into a license agreement with Sun Pharma Industries for tildrakizumab in Europe for psoriasis . Says to pay Sun Pharma an initial upfront payment of $50 million . Says Sun Pharma will be eligible to get milestone payments, sales milestone payments and royalties on net sales .Says phase-3 studies of tildrakizumab have recently been completed.  Full Article

Photo

India's Sun Pharma says U.S. finds more concerns at Halol plant

MUMBAI Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Wednesday the U.S. health regulator has informed the company of more concerns found at its Halol manufacturing plant after a recent inspection.